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ABSTRACT
We have used a method previously described by Reeves and
Candido (1) to partially release histone deacetylase from cell
nuclei together with putative regulators of the enzyme. Histone
deacetylase released from testis cell nuclei and its putative
regulators were separated by gel filtration on Sepharose 6B.
A peak of low molecular weight contains a heat-stable factor
that stimulates histone deacetylase in vitro. Many of the
properties of the activator coincide with those of the protein
HMG-20 (ubiquitin). Ubiquitin isolated from testis cell nuclei
stimulated histone deacetylase in vitro. It has been suggested
that HMG-17 partially inhibits histone deacetylase in Friend
cell nuclei (2). In our system, HMG-17 shows no inhibitory
effect on histone deacetylase activity.
INTRODUCTION
Histones can be modified by acetylation in two different
ways. The NH2 of the amino-terminal serine in histones Hl
H2A and H4 is permanently acetylated with no significant
turnover of this group. In contrast, there is an extensive
acetylation and deacetylation of lysine residues in the
amino-terminal regions of all nucleosomal histones H2A, H2B,
H3 and H4 (3).
Numerous correlations have been observed between
acetylation of histones and gene activity (4). An increase
of histone acetylation precedes the induction of new RNA
synthesis in mitogen-stimulated lymphocytes (5), in
regenerating liver (6) and in hormone stimulated target
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cells (7). Conversely, in the mature sperm of Arbacia lixula,
where no RNA synthesis occurs, histones appear only in their
nonacetylated forms (8). The transcriptionally active
macronucleus of Tetrahymena pyriformis contains highly
acetylated histones, whereas the histones of the micronucleus
are not acetylated (9).
Histone acetylation may play a critical role in permiting
DNA interactions with RNA polymerase and other nonhistone
proteins. The acetylation of the amino-terminal arms of the
histones may result in a relaxation of DNA twists within the
nucleosome and also could have long-range effects on chromatin
coiling. Such a process would offer a structural basis for
permiting DNA interactions with chromosomal proteins involved
in transcription.
At present, is uncertain whether acetylation of histones
in active genes is metabolically stable or unstable (10). If
acetylations are stable only at few specific chromatin sites
but unstable at the nonspecific loci, histone deacetylase
should be inhibited at the specific sites by regulatory
molecules as has been proposed for HMG-14 and HMG-17 (2). If
alternatively, in active genes the turnover of acetyl groups
on the core histones of nucleosomes is extremely rapid (11)
and acetylations are stable only at the nonspecific loci of
chromatin, histone deacetylase should be active in transcrip-
tionally active chromatin.
An increased rate of deacetylation may be ascribed to
an increased accessibility of histone molecules to the
deacetylase and/or to a higher enzymatic activity in
transcribing chromatin. Assuming the second possibility,
it seemed likely that deacetylase activators could be present
in chromatin. To test the idea we have used a method
previously described by Reeves and Candido (1) that partially
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releases histone deacetylase from cell nuclei together with
putative regulators of the enzyme. We report here the
purification of a heat-stable activator of histone deacetylase
with many properties in common with the protein ubiquitin.
We also show that in our system the nonhistone chromosomal
protein HMG-17,previously reported to inhibit histone
deacetylase in Friend cell nuclei (2), shows no inhibitory
effect on histone deacetylase.
MATERIALS AND METHODS
Nuclear isolation and nuclease digestion.
Nuclei were isolated from fresh rooster testis by the
sucrose procedure previously described (12)except for the
buffer used (0.01 M Tris-HCl, pH 7.9, 0.01 M NaCl, 10 mM
MgCl2 containing 0.25 per cent Triton X-100 and 1 mM PMSF).
Purified nuclei were digested with DNase I (Sigma) under
conditions known to preferentially destroy active genes(13).
After 5 min. at 370C about 10 per cent of the chromatin DNA
was released. Digestion was terminated by chilling and
immediately adding EDTA to a final 5 mM concentration.
Preparation of activator-deficient histone deacetylase.
The soluble material recovered by centrifugation at
12,000 x g for 5 min. after DNase I digestion of nuclei was
made 0.35 M in NaCl and 20 ml were applied to a Sepharose 6B
column, 2.5 x 100 cm(14). Fractions of 8 ml were collected.
The eluate was monitored for histone deacetylase activity and
histone deacetylase activator as described below.
Preparation of histone deacetylase activator.
Fractions 57 to 65 obtained from the Sepharose 6B column
were pooled and heated at 9000 for 20 min. The heat-stable
supernatant was fractionated by chromatography on
hydroxylapatite. The hydroxylapatite column ( 2.5 x 20 )
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was equilibrated with 5 mM sodium phosphate (pH 6.8), washed
with the same medium and the active fraction was eluted with
50 mM sodivtu phosphate. The active fraction was further
purified by gel filtration on Sephadex G-75 which had been
previously equilibrated with 10 mM fris-HCl ( pH 7.1 ).
Assay for histone deacetylase activity.
The assay for enzymatic deacetylation of histone follows
the method proposed by Inoue and Fujimoto (15). Aliquots of
the fractions to be tested (400 p1) were added to 25 pl
portions of isotopically labeled histone solutions (58,800 cpm)
and incubated at 370C for 60 min. Reactions were terminated
by the addition of 25 pl of concentrated HC1. The released
3H-acetic acid was then extracted from the mixtures with 2 ml
of ethyl acetate, and 1 ml of the organic solvent phase was
counted in Bray's scintillation fluid (16). Radioactivity was
measured in an Intertechnique model SL 30 scintillation
spectrometer. The radioactive substrates used for histone
deacetylase assays were prepared by incubating testicular
cells in the presence of 3H-acetate. Fresh rooster testis
(50 g) were minced with scissors and gently dissociated with
a syringe in 5 volumes of minimum essential medium (Eagle).
The cell suspension was filtered, diluted to a final volume
of 250 ml and cycloheximide was added to a final concentration
of 0.2 mM. The cell suspension was incubated with 5 m(i of
3H-sodium acetate (Amersham, 300 m0i/mmol) at 370C for 1 hour.
Following incubation histones were extracted from chromatin
as Dreviously described (12) except that all media contained
6 mM sodium butyrate.
Histone deacetylase activator assay.
The assay mixture contained 100 pg of activator deficient
histone deacetylase and different amounts of the activator
solution. After incubation for 60 min at 370C, histone
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deacetylase was assayed by the procedures previously defined.
Isolation of HMG protein 17 and assay with histone deacetylase,
The high mobility group proteins were prepared from
rooster testis cell nuclei by the method of Goodwin et al.(17).
The chromatin was extracted three times with 0.35 M NaOl,
10 mM Tris (pH 7.4), 1 mM PMSF. Proteins were then fractionated
on the basis of their solubility in trichloroacetic acid.
The proteins soluble in 0.35 x NaeW were treated successively
with 2 per cent trichloroacetic acid (TcA) to precipitate the
low mobility group and with 10 per cent TCA to remove HMG-l
and HMG-2. The remaining HMG-14 and HMG-17 were precipitated
in 25 per cent TCA. The precipitate was redisolved in 7.5 mi
sodium borate (pH 8.8), 0.15 NW1W and purified HMG-17 was
obtained by chromatography on CM-Sephadex 0-25 (18). The
assay of HMG-17 with histone deacetylase was performed as
indicated in the previous paragraph. In some experiments
HMG's 14 and 17 were obtained and assayed with histone
deacetylase in rooster testis cell nuclei as described by
Reeves and Candido (2).
Enzymatic hydrolysis.
Tryptic digestion was performed for 30 min. at 370C with
100 ag/ml trypsin (Merck) and soybean trypsin inhibitor
(Merck) was then added to 500 pg/ml. Pronase digestion (Merck,
25 pg/ml) was carried out at 370C for 60 min. at pH 7.3. The
incubation was terminated by boiling for 15 min. Control
experiments showed that this treatment was sufficient to
destroy completely the protease activity without affecting
the histone deacetylase activator. Treatment with ribonuclease
(Merck, 85 pg/ml) was at 37*0 for 18 hours at pH 7.3.
Analytical technigques.
Amino acid analyses were carried out using a Beckman
amino acid analyzer after hydrolysis of the samples in 6 N
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H¢1 at 110 0 for 24 hours. No corrections were made for
hydrolytic losses. Proteins were analyzed electrophoretically
on 15 per cent acrylaMide slab gels by the method of Panyim
and Chalkley (19), and in exponential polyacrylamide-SDS gels
(10 %-16 %) as described by O'Parrell (20). The gels were
scanned with a model 2410 Gilford linear transport scanner.
Protein was determined by the procedure of Lowry et al. (21).
RESULTS
Activator deficient histone deacetylase
When purified nuclei from rooster testis cells were
incubated with DNase I under conditions known to preferentially
destroy active genes, about 10 per cent of the chromatin
DNA was released. The supernatant obtained after DNase I
digestion showed histone deacetylase activity. In order to









,Figure 1: Sepharose 6B chromatography of the soluble materal
released after DNase I digestion of rooster testis cell nuclei.
The saple was applied to a 2.5 x 100 cm column and eluted in
0.025 Tris g buffer, pH 7.3, at a flow rate of 25 ml per
hour. --): A288; (-0)t histone deacetylase activity,
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nuclear extract was fractionated by gel filtration on
Stpharose 6B. The separation achieved is ilustrated in Pig. 1,
which shows the position of histone deacetylase activity. The
fractions containing the enzymatic activity were. pooled and
stored at -4000.
Histone deacetylase activator.
Preparation of the histone deacetylase activator from
the nuclear DNase I digested material was facilitated by the
fact that the activator, unlike the enzyme, is heat-stable.
When the DNase I digested material was incubated for 20 min.
at 900C and then rapidly cooled to O0C, most of the proteins
floculated and after centrifugation the supernatant contained
the histone deacetylase activator without enzymatic activity.
When the fractions eluted from the Sepharose 6B column were
treated in a similar way, the activator was detected in
fractions 57 to 65 (Fig. 1). Assaying the activator with
activator deficient histone deacetylase, the data plotted
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Figure 2: Determination of relative activity of heat-stable
extract on activator-deficient histone deacetylase. Fractions
57 to 65 obtained from Sepharose 6B chromatography were pooled,




corresponded to a 4 fold stimulation of the basal activity.
One unit of activator is defined as the amount (pg) of
heat-treated extract required to stimulate activator deficient
histone deacetylase to a 50 per cent maximal stimulation.
The heat-stable supernatant was fractionated by
chromatography on hydroxylapatite. The active fraction eluted
with 50 mM sodium phosphate was further purified by gel
filtration on Sephadex G-75. The electrophoresis in
SDS-acrylamide gels of the different steps of purification
is shown in Fig. 3. The specific activity of the purified
histone deacetylase activator is 510 units/mg of protein.
1 2 34
Figure 3: Comparative polyacrylamide gel electrophoretic
patterns of different fractions obtained during the purification
of the histone deacetylase activator. Slot 1 displays the pro-
teins from the active fraction obtained after Sepharose 6B
chromatography. Slot 2 displays the proteins of the heat
stable supernatant. Slot 3 displays the active fraction
obtained from the hydroxylapatite column. Slot 4 displays the




The activator is a non-dialysable molecule (Spectrapor
3 tubing, Spectrum Medical Industries), trypsin and pronase
resistant and ribonuclease resistant. The molecular weight
of the activator is 9,000 by gel filtration and by SDS-
electrophoresis (Fig. 4 and 5 ). We have performed amino
acid analysis of the purified histone deacetylase activator
and the results are summarized in Table I. In this table the
amino acid composition of the histone deacetylase activator
and of the protein ubiquitin (22) are compared.
The molecular weight, chromatographic bevahior, thermal
ELUTION VOLUME (ml)
Figure 4: Gel filtration analysis of the histone deacetylase
activator. The active fraction eluted from the hydroxylapatite
column was introduced into a column of Sephadex G-75(l.5xlOOcm).
The column was equilibrated and eluted with 10 mM Tris-HCl
(pH 7.1). The eluate was monitored for histone deacetylase
activator ( 0-o--o). Insert : Molecular weight determination.
Marker proteins (open circles) : ovalbumin, chymotrypsinogen
and cytochrome c. The closed circle indicates the elution
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Figure 5: SDS-polyacrylamide gel electrophoretic analysis of
the histone deacetylase activator. The active fraction eluted
from the Sephadex G-75 column was analyzed by SDS-polyacryl-
amide gel electrophoresis. The electrophoretic mobility of the
single band of the gel is 0.78. Insert : Molecular weight
determination. Marker proteins (open circles): phosphorylase
b, bovine serum albumin, ovalbumin, carbonic anhydrase,soybean
trypsin inhibitor and <-lactalbumin. Closed circle: histone
deacetylase activator.
stability, resistance to proteases and amino acid analysis
of the histone deacetylase activator are very similar to the
properties of the protein ubiquitin. To further probe the
possible identity of this protein we have purified ubiquitin
by two different procedures and assayed the protein with
activator deficient histone deacetylase. Rooster testis
ubiquitin was purified from the high mobility group nonhisto3e
proteins by chromatography on Bio-Rex 70 (23) or by gel
filtration on Sephadex G-75 (24). rn both cases ubiquitin
stimulated the enzymatic activity in vitro to a maximal level





Amino acid composition of purified histone deacetylase
activator and calf thymus ubiquitin
Amino acid Ubiquitin Histone deacetylase
activator
Asp 6.97 6.85 (7)
Thr 7.10 6.03 (7)
Ser 3.40 4.21 (3)
Glu 12.56 11.92 (12)
Pro 3.26 3.32 (3)
Gly 3.85 4.53 (4)
Ala 2.00 2.85 (2)
Cys 0.00 0.00 (0)
Val 3.91 4.23 (4)
Met 0.73 1.48 (1)
Ile 6.49 5.36 (7)
Leu 9.20 7.85 (9)
Tyr 0.99 1.31 (1)
Phe 1.84 2.02 (2)
His 0.94 1.20 (1)
Lys 7.19 6.74 (7)
Arg 3.89 3.81 (4)
Trp 0.00 0.00 (0)
The data are presented as numbers of residues per molecule.
The molecular weight of the histone deacetylase activator
is assumed as 9,000. No corrections were made for hydrolytic
losses. Numbers given in parentheses are the number of
residues obtained from the sequence result. The amino acid
composition of calf thymus ubiquitin is from (22).
Effect of HMG-17 on histone deacetylase activity.
The high mobility group nonhistone proteins were isolated
from rooster testis chromatin by the method of Goodwin et al.
(17). Proteins were fractionated on the basis of their
solubility in trichloroacetic acid. Pure HMG-17 was obtained
from the fraction soluble in 10 per cent TCA by chromatography
on CM-Sephadex U-25 (Fig. 6 ). The electrophoresis of the peak
eluted at 0.3 M NaCl and of the 10 per cent TCA soluble
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Figure 6: CM-Sephadex C25 chromatography of 10 per cent TCA
soluble HMG proteins. Partially purified HMG proteins were
applied to a 2.5 x 16 cm column of CM-Sephadex C25 equilibrated
with 7.5 mM sodium borate buffer (pH 8.8). The polyacrylamide
gel electrophoresis of the peak eluted at 0.3 M NaCl shows
a single band with the mobility of HMG-17. (-** ) : A220
( ) : NaCl concentration.
HMG 17^
A B._ ......... ... _w _,
__
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Figure 7: Comparative polyacrylamide gel electrophoretic
patterns of different amounts of partially purified HMG-17.
Total HMG proteins were fractionated on the basis of their
solubility in trichloroacetic acid. The fraction soluble
in 10 % TCA shows HMG-17 as the main component (B) . When
the gel is overloaded, several contaminants appear (A).
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have performed amino acid analysis of purified HMG-17 and the
results are shown in Table II. In this Table the amino acid
composition of the HMG-17 from rooster testis is compared
with the known amino acid composition of chicken erythrocyte
HMG-17 (25).
Reeves and Candido (2) have reported partial inhibition
of histone deacetylase by HMG-14 and HMG-17. We have assayed
purified HMG-17 with activator deficient histone deacetylase
and the 10 per cent TCA soluble HMG proteins (mainly HMG-17)
with purified nuclei. In both cases we could not detect the
reDorted inhibitory effect of HMG-14 and HMG-17 on histone
deacetylase (Table III).
TABLE II
Amino acid composition of isolated HMG proteins from rooster
testis cell nuclei and nuclei of chicken erythrocytes (mol%)


















No corrections were made for hydrolytic losses.





Effect of 10 per cent TCA soluble HMG proteins and purified
HMG-17 on histone deacetylase activity assayed in vitro
Assay with activator deficient histone deacetylase (a)
Protein concentration (Ag/ml) per reaction
None 40 80 160 360
10% TCA soluble
HMG proteins 4,625 4,610 4,717 4,653 5,041
Purified
HMG-17 4,552 4,324 4,643 5,007 -
Assay with nuclei isolated from testis cells (b)
Protein concentration (jg/ml) per reaction
None 90 180 360 730
10%-TCA soluble
HMG proteins 7,480 7,330 7,740 7,928 7,854
Histone deacetylase activity is listed in the table as the
amount of 3H-acetate (cpm)released from the acetylated histones.
(a) The conditions of the assay are described in Materials and
Methods.
(b) The conditions of the assay are described in reference (2).
DISCUSSION
We report here the isolation from rooster testis cell
nuclei of a heat-stable activator of histone deacetylase.
Many of its properties coincide with those of the protein
ubiquitin. Moreover, ubiquitin isolated from testis cell
nuclei by two different procedures stimulates histone
deacetylase in vitro.
Ubiquitin is a small highly stable globular acidic
protein, widely distributed in prokaryotes and eukaryotes
with an amino acid sequence highly conserved during evolution
(26-28). One of the known functions of ubiquitin is the ATP
denendent breakdown of proteins to amino acids (29). The
substrates of this proteolitic system are covalent conjugates
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of proteins and ubiquitin.
Ubiquitin is present in chromatin in two different
forms : covalently conjugated and in the free state. Free
ubiquitin is localized in a domain of chromatin enriched in
DNA sequences which can be transcribed into cellular RNA
(23,30) and there is some evidence that increases in free
ubiquitin are associated with increased gene activity (31).
We may speculate that if ubiquitin has in vivo the same
stimulatory activity on histone deacetylase than in vitro ,
this protein might be responsible for the high turnover
(half life of 3 to 7 min) of acetyl groups on the core histone
of a small subeet of nucleosomes comprising no more than 10
to 15 per cent of chromatin (11). The bulk of acetylated
histones (40 per cent of H3 and H4) is deacetylated at an
approximately 10-fold slower rate (Ul).
Reeves and Candido (2) considered the possibility that
within the regions of transcriptionally active chromatin an
endogenous inhibitor of the histone deacetylase is selectively
localized. They suggested that the Droteins of the nonhistone
High Mobility Group, HMG-14 and HMG-17, present in active
chromatin, partially inhibit the deacetylase enzyme.
We investigated if HMG-17 from rooster testis cells
could inhibit histone deacetylase in our system. We have
shown that HMG-17 does not inhibit histone deacetylase
assayed in vitro. In addition, the HMG's 14 and 17 from
rooster testis isolated and assayed as described by Reeves
and Candido (2) show no effect on nuclear deacetylase
activity.
Our results agree, however, with those described by
Reeves and Candido (2) for the trout specific protein H6.
This protein has many similarities to calf thymus HMG-17
(3.2). Protein H6, present in active genes, does not cause
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any inhibitory effect on histone deacetylase.
Further studies are necessary to probe if ubiquitin has
stimulatory activity on histone deacetylase in vivo and to
determine the relationship between gene activity , rapid
turnover of acetyl groups in the core histone of a small
sub-set of nucleosomes and the localization of ubiquitin in
certain domains of chromatin.
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